Skip to main content

Table 1 Patients baseline characteristics at study inclusion

From: Renal impairment after liver transplantation - a pilot trial of calcineurin inhibitor-free vs. calcineurin inhibitor sparing immunosuppression in patients with mildly impaired renal function after liver transplantation

  All(n = 21) Group 1(n = 8) Group2(n = 13) P =
Age (years) 47.9 ± 11.3 47.3 ± 11.8 48.4 ± 11.5 0.71
Male/female 12/9 4/4 8/5  
Time after engraftment (months) 6 ± 3.1 6.3 ± 3.4 5.5 ± 2.8 0.71
Baseline creatinine (mg/dL) 1.5 ± 0.42 1.57 ± 0.46 1.45 ± 0.41 0.64
Baseline GFR (mL/min) 44.9 ± 9.9 42.2 ± 10.2 46.5 ± 9.8 0.33
Immunosuppression at the time of inclusion
Ciclosporin/through level (ng/ml) N = 10
(83.9 ± 14.5)
N = 5
(85.6 ± 17.6)
N = 5
(81.7 ± 12.4)
0.72
Tacrolimus/through level (ng/ml) N = 11
(9.1 ± 1.7)
N = 3
(9.2 ± 2.4)
N = 8
(9.1 ± 1.4)
0.73
Prednisone frequency/dose (mg/day) N = 7 (4.4 ± 1.5) N = 5 (5 ± 0) N = 2 (3 ± 2.8)  
  1. Values are given as mean ± SD.